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Abstract
Background: The Ras superfamily plays an important role in the control of cell signalling and division. Mutations
in the Ras genes convert them into active oncogenes. The Ras oncogenes form a major thrust of global cancer
research as they are involved in the development and progression of tumors. This has resulted in the exponential
growth of data on Ras superfamily across different public databases and in literature. However, no dedicated public
resource is currently available for data mining and analysis on this family. The present database was developed to
facilitate straightforward accession, retrieval and analysis of information available on Ras oncogenes from one
particular site.
Description: We have developed the RAS Oncogene Database (RASOnD) as a comprehensive knowledgebase that
provides integrated and curated information on a single platform for oncogenes of Ras superfamily. RASOnD
encompasses exhaustive genomics and proteomics data existing across diverse publicly accessible databases. This
resource presently includes overall 199,046 entries from 101 different species. It provides a search tool to generate
information about their nucleotide and amino acid sequences, single nucleotide polymorphisms, chromosome
positions, orthologies, motifs, structures, related pathways and associated diseases. We have implemented a
number of user-friendly search interfaces and sequence analysis tools. At present the user can (i) browse the data
(ii) search any field through a simple or advance search interface and (iii) perform a BLAST search and
subsequently CLUSTALW multiple sequence alignment by selecting sequences of Ras oncogenes. The Generic
gene browser, GBrowse, JMOL for structural visualization and TREEVIEW for phylograms have been integrated for
clear perception of retrieved data. External links to related databases have been included in RASOnD.
Conclusions: This database is a resource and search tool dedicated to Ras oncogenes. It has utility to cancer
biologists and cell molecular biologists as it is a ready source for research, identification and elucidation of the role
of these oncogenes. The data generated can be used for understanding the relationship between the Ras
oncogenes and their association with cancer. The database updated monthly is freely accessible online at http://
202.141.47.181/rasond/ and http://www.aiims.edu/RAS.html.
Background
The driving force behind oncogenesis is the transforma-
tion of normal cells to uncontrolled cell proliferation
and invasion. A number of genes involved in regulating
the expression, growth and survival of cells have been
identified in events leading to malignant transformation.
Ras (RAt Sarcoma) is a majorm u l t i g e n es u p e r f a m i l y
that has been implicated in approximately 30% of the
known human tumors [1]. The predominant cancers
involving Ras are associated with lung [2], colorectal
region [3,4], pancreas [5] and thyroid [6]. The activation
of Ras from a proto-oncogene into an oncogene results
from a point mutation in the gene [7]. The Ras onco-
genes cause hyperactive cell signalling and consequently
contribute to the abnormal growth of the cell. These
oncogenes have also been identified in human develop-
mental disorders [8]. The Ras genes are expressed in
nearly all tissues, though their expression levels may
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genes in human tumors are HRAS (Harvey-Ras), KRAS
(Kristen-Ras) and NRAS (neuroblastoma-Ras) which
vary in nature and specificity according to the cancer
type [9].
The Ras proto-oncogene encodes a 21 kDa (p21) small
monomeric guanine nucleotide-binding protein. The Ras
proteins play a central role in the control of normal and
transformed cell proliferation. They have the ability to
bind both guanosine triphoshate (GTP) and guanosine
diphosphate (GDP) and function as a molecular switch
in signal transduction by alternating between the inac-
tive GDP-bound state and the active GTP-bound form.
The Ras in the active form signals cell growth whereas
in the inactive state it cannot initiate these pathways.
This binary switch system of the Ras protein is localized
to conformational changes in two distinct regions com-
prising switch I and switch II [10]. The structural
changes in the mutated Ras hinder its ability to hydro-
lyse GTP. The molecular switch gets trapped in the
‘switch on’ state resulting in increased Ras-GTP levels.
The signalling pathway is thus continuously stimulated
which leads to oncogenesis [11]. The most commonly
observed point mutations in human tumors are at
codons 12/13, or 61. Mutations involving residues 59,
63, 116, 117 and 119 have also been implicated in the
oncogenic activation by Ras protein [12].
Ras was the first oncogene to be discovered among
the transforming genes of the Harvey and Kirsten mur-
ine sarcoma viruses [13,14]. Since then a large number
of Ras genes and proteins have been identified from dif-
ferent species including humans. On the basis of
sequence similarity to the founding members [15], the
Ras superfamily has been broadly classified into five
main families, Ras [16], Rho [17], Arf [18], Rab [19] and
Ran [20]. An additional family ‘Others’ has been
assigned where their function is not clear. The Ras
superfamily has grown and presently consists of over
150 members from humans [21]. Its orthologs have also
been identified from nearly 100 other species. This
superfamily has been the subject of several general
[12,21-24] and specific reviews emphasizing their role in
human and experimental cancer [25], cell signaling and
transformation [26,27], cell motility [28], and differential
functions in different tumors [29]. Most researchers
across the globe have focused mainly on the identifica-
tion, activation and clinical significance of these onco-
proteins. This has led to the accumulation of enormous
amount of data across numerous databases and in litera-
ture. There is no single database to our knowledge, pre-
sently available, where all information is contained on a
single platform. This knowledgebase, compiles data
from sequence to functional level accessible across
diverse databases to enable the user rapid access,
retrieval and analysis of information from one location.
Thus, RASOnD aims to provide a better understanding
of the Ras genes and proteins, their relationship with
respect to each other and cancer.
Construction and Content
Data Generation
The database was developed with the objective to allow
simple retrieval and exploratory analysis of information
related to Ras oncogenes at a single point. It harbors a
total of 199,046 entries from 101 species (Table 1). The
details in RASOnD have been extracted from diverse
public primary databases. The databases from which the
information has been derived include the various
resources available at National Centre for Biotechnology
Information (NCBI) like GenBank [30] and Online Men-
delian Inheritance in Man (OMIM), Kyoto Encyclopedia
of Genes and Genomes (KEGG) [31], Database of Pro-
tein domains, families and functional sites (PROSITE)
[32], Universal Protein Resource (UniProt) [33], Protein
Databank (PDB) [34] and literature (PubMed). Various
different keywords related to ‘Ras’ were used for extrac-
tion of data. The keywords combined with Ras included
‘gene/oncogene’, mutation, disease, expression, eukar-
yote and terms related to cancer like ‘carcinoma/carci-
nogenesis/oncogenesis/tumor/hyperplasia/malignancy’.
The search criteria also included expressions related to
Ras like ‘small monomeric G-proteins’, ‘GTP-binding
proteins’, ‘small GTPases’ and ‘Ras related GTPases’.W e
have also annotated the data according to the associated
cancer type as available in KEGG, OMIM and PubMed
before April, 2011. Links to external databases have
been included within each entry.
Table 1 Overview of the Information content in RASOnD
Data Type Number
Species 101
Ras Families (excluding sub-families) 6
Nucleotide FASTA Sequences 4,882
Protein FASTA Sequences 4,882
Single Nucleotide Polymorphisms (SNPs) 102,426
Chromosome Positions 1,033
Pfam Entries 16,161
Prosite Entries 1,656
Protein Profiles 61,025
Protein Patterns 4,900
PDB Structures 548
Kegg Orthologies 152
Kegg Entries 3,871
Related Diseases 30
Related Pathways 3,626
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We have developed and implemented RASOnD using
freely available online open source softwares. Apache
HTTP Server serves as the localhost with MySQL rela-
tional database management system at the backend for
storing and maintaining the data. The front end is
designed with the help of HTML and CSS whereas the
dynamic pages have been created through PHP. Parsing
scripts written in PERL using regular expression were
used to download data. The data is divided into 15 core
tables with details on gene description, their family and
sub-family, FASTA sequences - both nucleotide and
protein, patterns, profiles, chromosome positions,
related pathways, single nucleotide polymorphisms
(SNPs), structures and links to related databases (Figure
1). The generic genome browser, GBrowse [35], open
source molecular viewer JMOL [36] and TreeView [37]
for phylograms have been implemented for effortless
visualization and analysis. The user queries retrieve
information from relational database tables which is dis-
played on the web interface. A local BLAST [38,39] and
CLUSTALW [40] tool can be used to retrieve and com-
pare sequences of interest from within the database.
Utility
User Interface - Simple and Advanced Search
The interfaces in RASOnD are designed to facilitate
straightforward navigation and exploitation of tools inte-
grated in the database. The data stored in the RASOnD
can be accessed employing a variety of search queries
which allow the user to retrieve and analyze the data in
a simple way. The users can retrieve information from
the database through two user friendly interfaces com-
prising a ‘Simple’ and an ‘Advanced’ search. A search
through the database can be performed separately on a
particular feature in the simple search as well as simul-
taneously on multiple fields using the advanced search
option. The simple search allows the user to explore the
database by selecting a specific individual field from the
drop down menu. The user can perform a search by
entering the keyword or by selecting the options avail-
able in the interface. Various alternatives are present in
the simple search.
The “gene name or INSD (International Nucleotide
Sequence Database) accession number” can be input by
the user to extract all available information on a particu-
lar Ras oncogene (Figure 2). The “gene family” option
allows the investigator to select a family from the five
main families of Ras superfamily. The option of further
selecting a member from the subfamilies of Ras, Rab,
Rho, Ran, Arf/Sar family and Others is also incorpo-
rated. The information on all Ras oncogenes present in
a specific species can be retrieved by choosing the
“organism search” option from the dropdown menu.
The “motif search” allows the user to scan motifs
related to a gene. This comprises a pattern and a pro-
file search which generates data on exisiting patterns
and predicted motifs respectively obtained from PRO-
SITE scan. The user can also opt for the pathway of
interest where these oncogenes are involved via the
“pathway search” menu. The “chromosome position”
alternative permits the user to access the details for
genes present in a desired organism. Selection of the
desired organism will present a table pertaining to the
chromosome number and position and related KEGG
and NCBI entry.
We have incorporated the ‘Advance search” option to
allow search of multiple fields simultaneously. This
search includes all the fields available in the simple
search menu. The user in this interface can select speci-
fic features and thus restrict the field of search. The
user can (i) input the gene or explore all genes based on
the subsequent parameters (ii) use the different aspects
incorporated as a drop down menu to access all or one
entry from the various parameters like organism, Ras
family, related pathways, patterns, profiles and disease
and (iii) decide to include or exclude the protein struc-
tures and SNPs. Thus, the user can narrow down the
search to the requisite criterion by utilizing this inter-
face (Figure 3). The initial output from this interface
displays the user selection before providing the tabulated
results.
User Interface - Diseases
The Ras oncogenes have been implicated in a variety of
cancers and developmental disorders. The human can-
cers which have the presence of Ras oncogenes are
included as a dropdown menu under the ‘Disease’ sec-
tion. The user can choose the disease of interest from
this menu. On selection, initially a summary table on
human Ras members involved in the preferred disease is
returned with a ‘Browse’ button. The related Ras onco-
genes/proteins from other species are also indicated.
This page also furnishes a short description of the can-
cer type.
User Interface - Results
The results for each search are displayed in two parts.
An initial investigation using any of the search options
returns a summary table displayed in tabular format list-
ing the Ras oncogenes from different species with a
‘Browse’ button. A click on this button presents addi-
tional and detailed records on varied aspects of the
selected oncogene like gene name with the nucleotide
and protein sequences, KEGG orthology, pathways,
chromosome position, available structures, motifs and
SNPs for all the genes belonging to the selected organ-
ism (Figure 4). The diseases with Ras manifestation are
also exhibited which have been further hyperlinked to
KEGG. Users can graphically view the motifs via the
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the three-dimensional structure is available. The coordi-
nates can be downloaded or structures analysed with
the JMOL applet embedded in the database. A hyperlink
to RCSB Protein Data Bank has also been integrated.
Similarly, the nucleotide or protein sequence data at
each point can be retrieved or a local BLAST run to
obtain sequences similar to the one of interest. The
homologous sequences returned from the BLAST search
can be further selected for onward submission to
CLUSTALW for multiple sequence alignment. The
selection can be made via a click on the buttons pro-
vided on the edge of the sequence. We have also hyper-
linked each entry to the related databases like HPRD,
K E G G ,O M I Ma n dH G N C .I nt h eP a t h w a y sp a g et h e
results are presented as KEGG Pathway ID, related
organism, KEGG Entry and pathway image which can
be further chosen for obtaining detailed information on
the oncogene. Links to the KEGG database are included
for scrutiny of proteins implicated in that pathway.
Figure 1 RASOnD Database scheme. The conceptual scheme depicting the various components of the database.
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The analysis of the data within the database can be car-
ried out using the tools available in the database. Three
tools have been implemented. The users can utilize the
genome viewer, ‘GBrowse’ for browsing associated genes
and patterns and profiles of predicted motifs for the
selected oncogene. The user can carry out sequence
similarity searches from within the database using ‘RAS-
ON-DBLAST’. The user-defined query nucleotide or
protein sequence in FASTA format can be submitted
for a local BLAST search against the database to identify
homologous sequences. The default or user-defined
parameters like e-value cutoff, gap opening, word size or
matrix can be modified for such a search. The user can
choose sequences returned for direct onward submission
to CLUSTALW or download the selected sequences for
any other analysis. “CLUSTALW” can be used for the
multiple sequence alignment of the selected sequences
obtained from the database query. The user can also
enter additional sequences of interest. The phylograms
g e n e r a t e df r o mC L U S T A L Wt o o lc a nb eo b s e r v e dw i t h
TreeView.
Additional features
T h eh o m ep a g ei n c l u d e saF A Qp a g ew i t ht h ep u r p o s e
of providing basic facts on the Ras superfamily as well
as the usage of the entire database. This page also
includes a section which is hyperlinked to reviews
available in literature. A download option has been
provided to obtain data related to nucleotide sequences,
protein sequences, single nucleotide polymorphisms and
protein structures as separate files. Links to other data-
bases which refer to some Ras superfamily members
and latest available literature from PubMed have also
been included on the home page.
Discussion
The main focus of research in molecular cancer is not
only the identification of the genes altered in different
tumor types but also determination of the pathological
role played by them in tumorogenesis. The Ras genes
and proteins are particularly very significant as they are
activated by point mutations and are the predominant
oncogenes in human tumors. The comprehension of dif-
ferent single amino acid substitutions which lead to
Figure 2 Screen shots of User Interface - Simple Search. Simple
search query using one of the six options provided e.g. Gene
Name. This query on providing the gene name results in a page
containing the organism name, the gene description and a ‘Browse’
button. A click on this button provides details related to that
particular gene. The red arrows indicate the pages obtained on
clicking the ‘Submit’ button
Figure 3 Screen shots of User Interface - Advanced Search. The
advanced search interface where more than one option can be
selected simultaneously to obtain varied information about the Ras
gene/protein. The user can choose to include or exclude any of the
options provided. The user has to input the gene name of interest
and then further pick either a parameter from the drop down menu
or decide on one of the default buttons incorporated for the
search. Submission of this option returns the genes according to
the search criteria. A click on the ‘Browse’ button will return detailed
data on the selected gene.
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to elucidate the mechanisms of oncogenesis. Moreover,
the Ras dependent pathways are now being targeted for
the development of anti-cancer agents. The objective of
this database is to amalgamate information distributed
across diverse platforms to a single site. It stores data
related to Ras genes and proteins, related polymorph-
isms, their pathways, associated diseases, motifs and
structures. It also contains tools for the examination
and analysis of these sequences. It thus, serves as an
Figure 4 Screen shots of User Interface - Result Page. Collage of some of the results produced via the ‘Browse’ button in both ‘Simple’ and
‘Advanced’ search options.
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community for research on Ras superfamily. This
resource has been designed to allow the user to explore
and extract effortlessly all accessible facts at one com-
mon place. RASOnD attempts to bridge the gap
between the genomics and system biology and affords
inputs and links to all aspects of Ras oncogenes not
accessible as a central resource so far. RASOnD is of
interest to molecular oncologists and researchers work-
ing in the field of cancer as it brings under one roof,
data for which otherwise a search would have to be con-
ducted across varied resources. It, therefore, serves as a
useful platform for ready reference for identification,
determination and comparative analysis of the genes
and proteins belonging to the Ras superfamily.
Comparison to other related Databases
There is no similar database to RASOnD, however,
there exist a small number of databases which have
some reference to the ‘Ras’ gene/protein “see Additional
file 1, Figure S1”. These deal with only a few species
(unlike the present which includes information on all
available species) or present specific rather than general-
ized and detailed information on the ‘Ras’ superfamily.
Majority have a focus on genomics rather than a proteo-
mics approach unlike RASOnD which provides detailed
i n f o r m a t i o no nb o t ha s p e c t s . These databases include
ACTuDB [41], Catalog of Somatic Mutations in Cancer
(COSMIC) database [42], Dragon database for explora-
tion of ovarian cancer genes (DDOC) [43], kinase path-
way database [44], mouse genome database [45],
Oncogenomic Database of Hepatocellular carcinoma
(OncoDB.HCC) [46], rat genome database (RGD) [47],
Signal Transduction Classification (STCDB) [48],
Tumor gene family of databases (TGDB) [49] and
Genecards [50]. The rat and mouse genome databases
are useful if the focus of search is on these species.
COSMIC database contains information on published
somatic mutations only in various cancers and refers
to just four families of Ras in humans. The DDOC and
OncoDB.HCC resources are specific to Ras members
implicated in ovarian cancer and hepatocellular carci-
noma respectively. The DDOC deals with human Ras
members whereas OncoDB.HCC comprises details on
rat and mouse besides human members. The ACTuDB
contains information on the genomic profiling of
tumors only with little emphasis on Ras oncogenes
while STCDB has reference to a handful of Ras genes/
proteins implicated in signal transduction. The Kinase
pathway database refers to only seven species. The
G e n e C a r d sc o n t a i n st h em a x i m u mn u m b e ro fR a s
members after RASOnD, however, it also refers to only
some species. A link to these databases is available on
t h eh o m ep a g e .
RASOnD is distinct from these published on-line public
databases. The main differentiating feature is the inclusion
of genomics and proteomics data from all species where
Ras members have been identified. Thus, it is the single,
specialized largest repository of Ras oncogenes. The pur-
pose of developing RASOnD was to provide a simple solu-
tion to clinicians and oncologists to extract information
on this gene. Moreover, it affords the alternative of select-
ing the disease of interest rather than just the Ras onco-
gene. The initial exploratory sequence analysis from
BLAST can further be exploited for multiple sequence
alignment with CLUSTALW by a one step selection of the
returned sequences. This is a feature unique to the present
database. In this manner, the concept of RASOnD is dif-
ferent from other available databases.
Future Directions
The present database focuses mainly on the genes and
proteins included in the Ras superfamily, their integra-
tion and involvement in different tumors and provides
tools for their analysis. We further plan to extend the
database with a greater emphasis on the Ras proteins to
include their post-translation modifications, interacting
partners and inhibitors. Proteins containing the RAS-
binding domain will also be incorporated into the
database.
Conclusion
The RASOnD knowledgebase is the first attempt to con-
struct an easily accessible and handy platform on the
multifaceted large Ras superfamily. RASOnD presents
the end-user with all possible details for analysis and
retrieval on various aspects of RAS oncogenes in a sim-
ple and user friendly manner. Details about various
other databases with reference to the Ras have been
included. The information in the database can be
accessed and investigated by a single query search or by
a combination of various queries. Alternatively, the
researcher can determine the Ras oncogene involved in
a particular cancer type by exercising the dropdown
menu under diseases. JMOL, GBrowse and TreeView
have been implemented for easy visualization whereas
BLAST and CLUSTALW modules have been incorpo-
rated for comparative analysis of sequences within the
database. The wealth of information available in
RASOnD can thus be exploited by both bench side
workers and bioinformaticians to carry out a compre-
hensive analysis on the Ras superfamily. The computa-
tional biologists can utilize the compiled data to develop
computational prediction tools for novel mutations.
Availability and Requirements
The RASonD database will be continuously updated and
upgraded and is freely available at http://www.aiims.edu/
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and non-academic users. Java enabled client web brow-
ser is required for the usage of the tools GBrowse, Jmol
applet and Treeview.
Additional material
Additional file 1: Figure S1 - Comparison to other related
databases. A three-dimensional bar plot indicating the comparison of
‘Ras - related’ information incorporated in RASOnD with other related
resources.
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